Impact of Chisan® (ADAPT-232) on the quality-of-life and its efficacy as an adjuvant in the treatment of acute non-specific pneumonia

Phytomedicine

Volumn 12, Issue 10, 2005, Pages 723-729

  Narimanian, M ^a   Badalyan, M ^a   Panosyan, V ^a   Gabrielyan, E ^b   Panossian, A ^b   Wikman, G ^c   Wagner, H ^d  

^a YEREVAN STATE MEDICAL UNIVERSITY   (Armenia)

^b Guelbenkian Research Laboratory   (Armenia)

^c Swedish Herbal Institute   (Sweden)

^d UNIVERSITY OF MUNICH   (Germany)

Author keywords

ADAPT 232; Adaptogens; Chisan ; Eleutherococcus senticosus; Mental performance; Placebo controlled parallel group clinical trials; Quality of life; Rhodiola rosea; Schisandra chinensis

Indexed keywords

ADAPT 232; BROMHEXINE; CEFAZOLIN; CHISAN; ELEUTEROCOCCUS SENTICOSUS EXTRACT; HERBACEOUS AGENT; PLANT EXTRACT; RHODIOLA EXTRACT; SCHISANDRA CHINENSIS EXTRACT; THEOPHYLLINE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ELEUTHEROCOCCUS SENTICOSUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHASE 3 CLINICAL TRIAL; PNEUMONIA; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RHODIOLA; RHODIOLA ROSEA; SCHISANDRA ROSEA; SCHISANDRACEAE; SELF EVALUATION; TREATMENT OUTCOME; ACUTE DISEASE; BACTERIAL PNEUMONIA; DRUG COMBINATION; ELEUTHEROCOCCUS; MIDDLE AGED; PHYTOTHERAPY; PILOT STUDY; PSYCHOLOGICAL ASPECT; PSYCHOMETRY;

ELEUTHEROCOCCUS SENTICOSUS; RHODIOLA ROSEA; SCHISANDRA CHINENSIS;

ACUTE DISEASE; ADULT; ANTI-BACTERIAL AGENTS; CEFAZOLIN; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; ELEUTHEROCOCCUS; FEMALE; HUMANS; MALE; MIDDLE AGED; PHYTOTHERAPY; PILOT PROJECTS; PLANT EXTRACTS; PNEUMONIA, BACTERIAL; PSYCHOMETRICS; QUALITY OF LIFE; RHODIOLA; SCHISANDRA;

EID: 27144465987     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2004.11.004     Document Type: Article

References (12)

1. I.I. Brekhman, and I.V. Dardymov New substances of plant origin which increase non-specific resistance Annu. Rev. Pharmacol. 8 1968 419 430
2. J.A. Cramer, and B. Spilker Quality of Life and Pharmacoeconomics. An Introduction 1998 Lippincott-Raven Philadelphia
3. G. Huchon, M. Woodhead, G. Gialdroni-Grassi, P. Leophonte, F. Manresa, T. Schaberg, A. Torres, A. Didier, J. Dorca, M. El Ebiary, and N. Roche Guidelines for management of adult community-acquired lower respiratory tract infections Eur. Resp. J. 11 1998 986 991
4. M.S. Niederman, J.B. Bass, G.D. Campbell, A.M. Fein, R.F. Grossman, L.A. Mandell, T.J. Marrie, G.A. Sarosi, A. Torres, and V.L. Yu Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy Am. Rev. Respir. Dis. 148 1993 1418 1426
5. M.S. Niederman, L.A. Mandell, A. Anzueto, J.B. Bass, W.A. Broughton, G.D. Campbell, N. Dean, T. File, M.J. Fine, P.A. Gross, F. Martinez, T.J. Marrie, J.F. Plouffe, J. Ramirez, G.A. Sarosi, A. Torres, R. Wilson, and V.L. Yu Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention Am. J. Respir. Crit. Care Med. 163 2001 1730 1754
6. A.G. Panossian Adaptogens: tonic herbs for fatigue and stress Altern. Compliment Ther. 9 2004 327 332
7. A. Panossian, G. Wikman, and H. Wagner Plant adaptogens III: earlier and more recent aspects and concepts on their modes of action Phytomedicine 6 1999 287 300
8. Spanish Thoracic Society National recommendations for diagnosis and treatment of community-acquired pneumonia. SEPAR 1992 Edidiones Doyma SA Barcelona
9. H. Schipper Guidelines and caveats for quality of life measurement in clinical practice and research Oncology (Huntingt). 1990 May 4 5 1990 51 57
10. World Health Organization WHOQOL Study Protocol (MNH/PSF/93.9) 1993 WHO Geneva
11. World Health Organization WHOQOL-Bref - Introduction, Administration, Scoring and Generic Version of the Assessment. Field Trial Version 1996 WHO Geneva
12. World Medical Association Declaration of Helsinki, 2000. Ethical principles for medical research involving human subjects. 18th WMA General Assembly, Helsinki (Finland) June 1964 and 52nd WMA General Assembly, Edinburgh (Scotland), October 2000.